HongYua,b,KaiLua,b,andJiananWanga,b,*.Treatmentofheartfailureaftermyocardialinfarctionwithbonemarrow-derivedmesenchymalstemcells.
CardiologyPlus
《门诊》获授权转载。
aDepartmentofCardiology,SecondAffiliatedHospital,CollegeofMedicine,ZhejiangUniversity,Hangzhou,,PRChina;
bCardiovascularKeyLaboratoryofZhejiangProvince,Hangzhou,,PRChina;
*Correspondingauthors:JiananWang,MD,PhD,DepartmentofCardiology,SecondAffiliatedHospital,CollegeofMedicine,ZhejiangUniversity,Hangzhou,China.
AbstractHeartfailure(HF)aftermyocardialinfarction(MI)representsaworldwidepublichealthissuewithgraduallyincreasingincidence.HFmayeventuallyaffectallorgansandtissues,andisassociatedwithsignificantmorbidityandmortality.CurrenttherapeuticmethodstotreatHFstayatonlydelayingthediseaseprogressionwithoutrepairandregeneration.Recently,celltransplantationhasgraduallybe北京看白癜风去哪个医院最好那些偏方能治白癜风
转载请注明:http://www.shhongrui.net/xjgfz/440.html